Contraindicated (one)bortezomib will increase the stage or effect of mavacamten by affecting hepatic enzyme CYP2C19 metabolism. Contraindicated. Sturdy or average CYP2C19 inhibitors may perhaps boost mavacamten systemic exposure, leading to heart failure on account of systolic dysfunction. Unlock 38% much more drug discovery time and get rid of selection-producing doubts https://juliak381npj4.dailyhitblog.com/profile